Filing metadata

Accession number
0001445826-26-000018
Form type
Form 4
Filer
Agomab Therapeutics NV
CIK
CIK 2020932
Filed
Nov 06, 2026
Reporting period
Nov 05, 2026
Description
Insider transaction

Explore SEC Filings Hub